Ekaterina Galanzha
Concepts (267)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Flow Cytometry | 34 | 2024 | 476 | 5.140 |
Why?
| Neoplastic Cells, Circulating | 18 | 2020 | 74 | 4.540 |
Why?
| Photoacoustic Techniques | 21 | 2024 | 72 | 4.500 |
Why?
| Molecular Imaging | 13 | 2016 | 53 | 2.410 |
Why?
| Nanoparticles | 13 | 2019 | 152 | 1.840 |
Why?
| Acoustics | 8 | 2016 | 33 | 1.810 |
Why?
| Light | 9 | 2017 | 71 | 1.520 |
Why?
| Temperature | 7 | 2016 | 168 | 1.380 |
Why?
| Single-Cell Analysis | 3 | 2019 | 61 | 1.260 |
Why?
| Magnetite Nanoparticles | 4 | 2019 | 21 | 1.220 |
Why?
| Gold | 14 | 2019 | 136 | 1.180 |
Why?
| Mesentery | 8 | 2011 | 32 | 1.170 |
Why?
| Mice | 32 | 2019 | 5759 | 1.010 |
Why?
| Animals | 48 | 2019 | 13246 | 0.990 |
Why?
| Lasers | 15 | 2017 | 123 | 0.990 |
Why?
| Mice, Nude | 16 | 2018 | 254 | 0.920 |
Why?
| Luminescent Proteins | 2 | 2014 | 55 | 0.920 |
Why?
| Lymphatic Vessels | 5 | 2019 | 48 | 0.880 |
Why?
| Cell Line, Tumor | 18 | 2019 | 1416 | 0.820 |
Why?
| Lymphatic System | 2 | 2018 | 14 | 0.710 |
Why?
| Quantum Dots | 3 | 2017 | 12 | 0.690 |
Why?
| Lymph | 5 | 2019 | 19 | 0.690 |
Why?
| Sentinel Lymph Node Biopsy | 1 | 2020 | 117 | 0.680 |
Why?
| Metal Nanoparticles | 7 | 2017 | 85 | 0.680 |
Why?
| Erythrocytes | 5 | 2024 | 83 | 0.670 |
Why?
| Contrast Media | 9 | 2017 | 185 | 0.660 |
Why?
| Melanoma | 3 | 2019 | 290 | 0.660 |
Why?
| Meningeal Neoplasms | 1 | 2019 | 52 | 0.650 |
Why?
| Nanotechnology | 4 | 2015 | 36 | 0.650 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2018 | 6 | 0.640 |
Why?
| Therapeutics | 1 | 2018 | 5 | 0.640 |
Why?
| Optics and Photonics | 1 | 2018 | 11 | 0.630 |
Why?
| Nanotubes, Carbon | 11 | 2011 | 68 | 0.590 |
Why?
| Neoplastic Stem Cells | 3 | 2020 | 103 | 0.580 |
Why?
| Silicon Dioxide | 1 | 2017 | 17 | 0.580 |
Why?
| Fluorescent Dyes | 7 | 2019 | 106 | 0.570 |
Why?
| Rats | 15 | 2019 | 3299 | 0.570 |
Why?
| Melanoma, Experimental | 3 | 2016 | 45 | 0.560 |
Why?
| Cardiovascular Diseases | 2 | 2012 | 443 | 0.550 |
Why?
| Lymphatic Metastasis | 4 | 2020 | 227 | 0.530 |
Why?
| Brain Neoplasms | 1 | 2019 | 288 | 0.530 |
Why?
| Neoplasms | 10 | 2019 | 1249 | 0.520 |
Why?
| Microscopy, Fluorescence | 6 | 2012 | 166 | 0.500 |
Why?
| Microscopy | 4 | 2018 | 57 | 0.480 |
Why?
| Anemia, Sickle Cell | 2 | 2016 | 96 | 0.480 |
Why?
| Cell Tracking | 1 | 2014 | 2 | 0.480 |
Why?
| Blood Coagulation | 2 | 2011 | 56 | 0.450 |
Why?
| Magnetics | 3 | 2011 | 39 | 0.450 |
Why?
| Hemorheology | 3 | 2011 | 11 | 0.440 |
Why?
| Cerebrospinal Fluid | 1 | 2013 | 32 | 0.440 |
Why?
| Carotenoids | 1 | 2012 | 21 | 0.420 |
Why?
| Phototherapy | 5 | 2019 | 45 | 0.420 |
Why?
| Blood Circulation | 2 | 2009 | 15 | 0.420 |
Why?
| Melanins | 4 | 2012 | 27 | 0.420 |
Why?
| Humans | 35 | 2024 | 50208 | 0.410 |
Why?
| Laser Therapy | 2 | 2009 | 84 | 0.400 |
Why?
| Bacteremia | 1 | 2012 | 92 | 0.390 |
Why?
| Bacteria | 1 | 2013 | 222 | 0.380 |
Why?
| Leukocytes | 2 | 2016 | 67 | 0.380 |
Why?
| Image Cytometry | 4 | 2011 | 12 | 0.380 |
Why?
| Thromboembolism | 1 | 2011 | 54 | 0.370 |
Why?
| Laser Scanning Cytometry | 3 | 2010 | 8 | 0.370 |
Why?
| Skin Neoplasms | 3 | 2011 | 492 | 0.360 |
Why?
| Neoplasm Metastasis | 2 | 2015 | 236 | 0.350 |
Why?
| Models, Animal | 3 | 2010 | 232 | 0.350 |
Why?
| Cell Separation | 5 | 2008 | 90 | 0.350 |
Why?
| Lasers, Semiconductor | 1 | 2009 | 10 | 0.350 |
Why?
| Hot Temperature | 6 | 2013 | 205 | 0.340 |
Why?
| Image Interpretation, Computer-Assisted | 4 | 2007 | 106 | 0.340 |
Why?
| Staphylococcal Infections | 1 | 2012 | 269 | 0.340 |
Why?
| Early Detection of Cancer | 2 | 2016 | 167 | 0.340 |
Why?
| Microscopy, Acoustic | 1 | 2008 | 5 | 0.320 |
Why?
| Nanotubes | 3 | 2019 | 27 | 0.320 |
Why?
| Spectrum Analysis | 7 | 2013 | 71 | 0.300 |
Why?
| Breast Neoplasms | 5 | 2018 | 1179 | 0.300 |
Why?
| Myocardial Infarction | 1 | 2011 | 396 | 0.290 |
Why?
| Blood Vessels | 2 | 2018 | 71 | 0.280 |
Why?
| Fluorescence | 4 | 2018 | 41 | 0.280 |
Why?
| Drug Evaluation, Preclinical | 1 | 2007 | 143 | 0.270 |
Why?
| Drug Delivery Systems | 2 | 2019 | 146 | 0.270 |
Why?
| Stroke | 1 | 2011 | 493 | 0.270 |
Why?
| Neoplasm Recurrence, Local | 2 | 2020 | 613 | 0.260 |
Why?
| Nicotinic Agonists | 1 | 2005 | 56 | 0.260 |
Why?
| Lymph Nodes | 3 | 2020 | 263 | 0.260 |
Why?
| Nanospheres | 2 | 2017 | 8 | 0.260 |
Why?
| Spectrum Analysis, Raman | 4 | 2014 | 58 | 0.260 |
Why?
| Blood Cells | 4 | 2012 | 43 | 0.250 |
Why?
| Microscopy, Electron, Transmission | 4 | 2017 | 75 | 0.250 |
Why?
| Early Diagnosis | 4 | 2016 | 87 | 0.250 |
Why?
| Green Fluorescent Proteins | 3 | 2019 | 91 | 0.240 |
Why?
| Nicotine | 1 | 2005 | 187 | 0.240 |
Why?
| Antibodies | 4 | 2014 | 154 | 0.240 |
Why?
| Color | 3 | 2016 | 22 | 0.230 |
Why?
| Photochemical Processes | 2 | 2014 | 9 | 0.230 |
Why?
| Microscopy, Confocal | 2 | 2015 | 89 | 0.220 |
Why?
| Hyperthermia, Induced | 2 | 2019 | 117 | 0.220 |
Why?
| Folic Acid | 2 | 2017 | 137 | 0.220 |
Why?
| Thermography | 3 | 2009 | 11 | 0.210 |
Why?
| Cell Count | 2 | 2019 | 149 | 0.210 |
Why?
| Rats, Sprague-Dawley | 5 | 2019 | 1586 | 0.210 |
Why?
| Hemeproteins | 2 | 2024 | 8 | 0.200 |
Why?
| Parasitemia | 2 | 2024 | 8 | 0.200 |
Why?
| Mice, Transgenic | 2 | 2016 | 550 | 0.190 |
Why?
| Staining and Labeling | 2 | 2013 | 97 | 0.190 |
Why?
| Plant Leaves | 2 | 2011 | 40 | 0.190 |
Why?
| Malaria | 2 | 2024 | 37 | 0.190 |
Why?
| Cell Survival | 3 | 2018 | 602 | 0.180 |
Why?
| Disease Models, Animal | 3 | 2016 | 1458 | 0.180 |
Why?
| Photometry | 4 | 2010 | 14 | 0.170 |
Why?
| Protein Engineering | 1 | 2019 | 18 | 0.170 |
Why?
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 13 | 0.170 |
Why?
| Muscle Cells | 1 | 2019 | 22 | 0.170 |
Why?
| Nanocomposites | 1 | 2019 | 9 | 0.160 |
Why?
| Signal Processing, Computer-Assisted | 2 | 2011 | 70 | 0.160 |
Why?
| Muscle Contraction | 1 | 2019 | 106 | 0.160 |
Why?
| Doxorubicin | 1 | 2019 | 239 | 0.150 |
Why?
| Drug Carriers | 2 | 2015 | 71 | 0.150 |
Why?
| Lymphatic Abnormalities | 1 | 2017 | 22 | 0.150 |
Why?
| Materials Testing | 1 | 2017 | 58 | 0.140 |
Why?
| Optical Phenomena | 2 | 2017 | 10 | 0.140 |
Why?
| Molecular Probes | 1 | 2016 | 9 | 0.140 |
Why?
| Biocompatible Materials | 1 | 2017 | 69 | 0.140 |
Why?
| Staphylococcus aureus | 2 | 2012 | 327 | 0.140 |
Why?
| Image Enhancement | 2 | 2006 | 54 | 0.140 |
Why?
| Embolism | 1 | 2016 | 20 | 0.140 |
Why?
| Microscopy, Video | 2 | 2006 | 13 | 0.140 |
Why?
| Escherichia coli | 2 | 2007 | 186 | 0.140 |
Why?
| Transducers | 1 | 2016 | 20 | 0.130 |
Why?
| Exosomes | 1 | 2016 | 50 | 0.130 |
Why?
| Ultrasonics | 1 | 2016 | 31 | 0.130 |
Why?
| Plasmodium yoelii | 1 | 2016 | 14 | 0.130 |
Why?
| Reproducibility of Results | 3 | 2016 | 1185 | 0.130 |
Why?
| Ultrasonography | 2 | 2007 | 437 | 0.120 |
Why?
| Apoptosis | 2 | 2018 | 1112 | 0.120 |
Why?
| Image Processing, Computer-Assisted | 3 | 2018 | 246 | 0.120 |
Why?
| Pharmaceutical Preparations | 1 | 2015 | 79 | 0.120 |
Why?
| Plant Roots | 2 | 2011 | 33 | 0.120 |
Why?
| Magnetic Phenomena | 1 | 2013 | 6 | 0.120 |
Why?
| Diagnostic Imaging | 2 | 2017 | 177 | 0.120 |
Why?
| Silver | 1 | 2014 | 47 | 0.110 |
Why?
| Particle Size | 1 | 2013 | 80 | 0.110 |
Why?
| Sensitivity and Specificity | 4 | 2024 | 863 | 0.110 |
Why?
| Mosquito Control | 1 | 2013 | 4 | 0.110 |
Why?
| Mammary Neoplasms, Animal | 1 | 2013 | 35 | 0.110 |
Why?
| Aedes | 1 | 2013 | 12 | 0.110 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.110 |
Why?
| Antineoplastic Agents | 2 | 2013 | 1186 | 0.110 |
Why?
| Complementary Therapies | 1 | 2012 | 25 | 0.100 |
Why?
| Lipoproteins | 1 | 2012 | 38 | 0.100 |
Why?
| Receptors, Cell Surface | 2 | 2009 | 125 | 0.100 |
Why?
| Erythrocyte Deformability | 1 | 2011 | 2 | 0.100 |
Why?
| Erythrocyte Aggregation | 1 | 2011 | 3 | 0.100 |
Why?
| Xylem | 1 | 2011 | 3 | 0.100 |
Why?
| Phloem | 1 | 2011 | 3 | 0.100 |
Why?
| Blood Viscosity | 1 | 2011 | 4 | 0.100 |
Why?
| Systems Integration | 3 | 2007 | 22 | 0.100 |
Why?
| Succinimides | 1 | 2011 | 7 | 0.100 |
Why?
| Fluoresceins | 1 | 2011 | 15 | 0.100 |
Why?
| Hematocrit | 1 | 2011 | 45 | 0.100 |
Why?
| Splanchnic Circulation | 1 | 2011 | 40 | 0.100 |
Why?
| Tumor Cells, Cultured | 2 | 2009 | 468 | 0.100 |
Why?
| Blood Volume | 1 | 2011 | 69 | 0.100 |
Why?
| Platelet Aggregation | 1 | 2011 | 71 | 0.100 |
Why?
| Carotid Arteries | 1 | 2011 | 85 | 0.100 |
Why?
| KB Cells | 1 | 2010 | 5 | 0.090 |
Why?
| Hemoglobins | 1 | 2011 | 107 | 0.090 |
Why?
| Cytochromes c | 1 | 2010 | 29 | 0.090 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2013 | 388 | 0.090 |
Why?
| Gene Expression Regulation, Plant | 1 | 2010 | 42 | 0.090 |
Why?
| Time Factors | 3 | 2018 | 2922 | 0.090 |
Why?
| Folate Receptors, GPI-Anchored | 1 | 2009 | 7 | 0.090 |
Why?
| Rheology | 1 | 2009 | 7 | 0.090 |
Why?
| Endothelium, Lymphatic | 2 | 2009 | 12 | 0.090 |
Why?
| Ablation Techniques | 1 | 2009 | 21 | 0.090 |
Why?
| Lymphography | 1 | 2009 | 9 | 0.090 |
Why?
| Molecular Mimicry | 1 | 2009 | 38 | 0.090 |
Why?
| Etoposide | 1 | 2009 | 72 | 0.090 |
Why?
| Spectrophotometry, Infrared | 1 | 2009 | 8 | 0.080 |
Why?
| Blood Chemical Analysis | 1 | 2009 | 27 | 0.080 |
Why?
| Adipocytes | 1 | 2010 | 121 | 0.080 |
Why?
| Cell Death | 1 | 2009 | 182 | 0.080 |
Why?
| Blood Platelets | 1 | 2011 | 249 | 0.080 |
Why?
| Neoplasms, Experimental | 1 | 2008 | 114 | 0.080 |
Why?
| Carrier Proteins | 1 | 2009 | 306 | 0.080 |
Why?
| Refractometry | 1 | 2007 | 5 | 0.080 |
Why?
| Blood Coagulation Tests | 1 | 2007 | 19 | 0.070 |
Why?
| Colony Count, Microbial | 1 | 2007 | 66 | 0.070 |
Why?
| Escherichia coli Infections | 1 | 2007 | 31 | 0.070 |
Why?
| Mitochondria | 1 | 2010 | 404 | 0.070 |
Why?
| Flow Injection Analysis | 1 | 2006 | 2 | 0.070 |
Why?
| Mesenteric Arteries | 1 | 2006 | 45 | 0.070 |
Why?
| Female | 4 | 2024 | 26635 | 0.070 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 828 | 0.060 |
Why?
| Indocyanine Green | 2 | 2019 | 34 | 0.060 |
Why?
| Rats, Inbred F344 | 1 | 2005 | 196 | 0.060 |
Why?
| Cell Culture Techniques | 1 | 2005 | 99 | 0.060 |
Why?
| Cameroon | 1 | 2024 | 4 | 0.060 |
Why?
| Microcirculation | 1 | 2005 | 71 | 0.060 |
Why?
| Plasmodium falciparum | 1 | 2024 | 18 | 0.060 |
Why?
| Malaria, Falciparum | 1 | 2024 | 13 | 0.060 |
Why?
| ROC Curve | 1 | 2024 | 232 | 0.060 |
Why?
| Infrared Rays | 2 | 2016 | 25 | 0.060 |
Why?
| Spectrophotometry | 2 | 2016 | 32 | 0.060 |
Why?
| Male | 5 | 2024 | 25399 | 0.060 |
Why?
| Longitudinal Studies | 1 | 2024 | 695 | 0.050 |
Why?
| Equipment Design | 3 | 2007 | 285 | 0.050 |
Why?
| Photochemistry | 2 | 2010 | 16 | 0.040 |
Why?
| Organ Culture Techniques | 1 | 2019 | 48 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2024 | 1554 | 0.040 |
Why?
| Staurosporine | 1 | 2018 | 12 | 0.040 |
Why?
| Kinetics | 2 | 2011 | 631 | 0.040 |
Why?
| Antibiotics, Antineoplastic | 1 | 2019 | 81 | 0.040 |
Why?
| HeLa Cells | 2 | 2009 | 260 | 0.040 |
Why?
| Computer Systems | 2 | 2009 | 21 | 0.040 |
Why?
| Nanomedicine | 1 | 2017 | 21 | 0.040 |
Why?
| Schizonts | 1 | 2016 | 3 | 0.030 |
Why?
| Ear | 1 | 2016 | 17 | 0.030 |
Why?
| Host-Parasite Interactions | 1 | 2016 | 16 | 0.030 |
Why?
| Equipment Failure Analysis | 2 | 2006 | 46 | 0.030 |
Why?
| Computers, Handheld | 1 | 2016 | 25 | 0.030 |
Why?
| Genes, Reporter | 1 | 2016 | 88 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2019 | 1378 | 0.030 |
Why?
| Drug Compounding | 1 | 2015 | 25 | 0.030 |
Why?
| Workflow | 1 | 2015 | 51 | 0.030 |
Why?
| Biological Transport | 1 | 2015 | 172 | 0.030 |
Why?
| Young Adult | 1 | 2024 | 3981 | 0.030 |
Why?
| Mammography | 1 | 2015 | 94 | 0.030 |
Why?
| Surface Plasmon Resonance | 1 | 2014 | 22 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2014 | 69 | 0.030 |
Why?
| Neoplasm Staging | 1 | 2016 | 738 | 0.030 |
Why?
| Biopsy | 1 | 2015 | 590 | 0.030 |
Why?
| Adolescent | 1 | 2024 | 6390 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2013 | 184 | 0.030 |
Why?
| Cells, Cultured | 2 | 2007 | 1581 | 0.030 |
Why?
| Radiation Dosage | 1 | 2013 | 157 | 0.030 |
Why?
| Intracellular Space | 1 | 2012 | 25 | 0.030 |
Why?
| Gentian Violet | 1 | 2011 | 4 | 0.020 |
Why?
| Optical Fibers | 1 | 2011 | 7 | 0.020 |
Why?
| Trypan Blue | 1 | 2011 | 6 | 0.020 |
Why?
| Hematologic Tests | 1 | 2011 | 10 | 0.020 |
Why?
| Methylene Blue | 1 | 2011 | 10 | 0.020 |
Why?
| Injections, Intravenous | 1 | 2011 | 143 | 0.020 |
Why?
| Cell Line | 1 | 2014 | 1021 | 0.020 |
Why?
| Aquaporin 2 | 1 | 2010 | 5 | 0.020 |
Why?
| Blood Loss, Surgical | 1 | 2011 | 72 | 0.020 |
Why?
| Caenorhabditis elegans | 1 | 2012 | 138 | 0.020 |
Why?
| Imaging, Three-Dimensional | 1 | 2012 | 153 | 0.020 |
Why?
| Microarray Analysis | 1 | 2010 | 73 | 0.020 |
Why?
| Immunoconjugates | 1 | 2011 | 38 | 0.020 |
Why?
| Neoplasm Transplantation | 1 | 2010 | 85 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2016 | 1819 | 0.020 |
Why?
| Chylomicrons | 1 | 2010 | 2 | 0.020 |
Why?
| Survival Rate | 1 | 2013 | 901 | 0.020 |
Why?
| Oscillometry | 1 | 2010 | 8 | 0.020 |
Why?
| Neovascularization, Pathologic | 1 | 2011 | 162 | 0.020 |
Why?
| Plant Oils | 1 | 2010 | 15 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2010 | 454 | 0.020 |
Why?
| Drug Synergism | 1 | 2009 | 151 | 0.020 |
Why?
| Middle Aged | 1 | 2024 | 12206 | 0.020 |
Why?
| Phantoms, Imaging | 1 | 2010 | 121 | 0.020 |
Why?
| Adult | 1 | 2024 | 13324 | 0.020 |
Why?
| Scattering, Radiation | 1 | 2007 | 31 | 0.020 |
Why?
| Oxidative Stress | 1 | 2012 | 771 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2006 | 101 | 0.020 |
Why?
| Algorithms | 1 | 2010 | 618 | 0.020 |
Why?
| Video Recording | 1 | 2005 | 80 | 0.020 |
Why?
| Treatment Outcome | 1 | 2009 | 5155 | 0.010 |
Why?
|
|
Galanzha's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|